How Much Adrenaline Is Lethal to the Human Body?

There is no single milligram threshold at which adrenaline (epinephrine) reliably kills a person. Published case reports show wildly divergent outcomes: a 51-year-old man died after receiving just 3 milligrams by intramuscular injection for an allergic reaction, while another patient accidentally received 5 milligrams intravenously and survived with intensive monitoring.¹ The lethal dose depends on the route it enters the body, how fast it gets there, the person’s age and heart health, and what other drugs are on board. That variability is the honest answer, and it is worth understanding why.

Why No Fixed Lethal Dose Exists

Most drugs have at least a rough lethal range established through animal studies and accidental human poisonings. Adrenaline is different for two reasons. First, your body already makes it continuously. Baseline endogenous release is roughly 0.18 micrograms per minute, and the body clears circulating adrenaline at about 33 to 35 milliliters per kilogram per minute.² That rapid clearance means a dose that would be lethal injected as a fast bolus might be tolerated if infused slowly, because the body metabolizes and removes it almost as quickly as it arrives.

Second, the toxic effects of adrenaline are not dose-proportional in a neat line. A small overshoot can trigger dangerous heart rhythms, while a much larger overshoot might produce severe but survivable symptoms if the patient receives immediate critical care. Case reports bear this out repeatedly. There are no standardized guidelines for treating epinephrine overdose precisely because the clinical picture varies so much from person to person.¹

Animal data offers a rough yardstick, though it translates poorly to humans. In mice, the LD50 for adrenaline injected under the skin sits around 11 milligrams per kilogram of body weight.³ Scaled to a 70-kilogram human, that would imply hundreds of milligrams, a number that has little clinical meaning because nobody receives subcutaneous adrenaline in those quantities. The human cases that end fatally typically involve just a few milligrams delivered by the wrong route or at the wrong speed.

Route of Administration Changes Everything

The standard emergency dose for anaphylaxis is 0.3 to 0.5 milligrams injected into the muscle of the outer thigh. At that dose and by that route, serious cardiovascular side effects occur in roughly 1 percent of cases. But when the same drug is pushed as an intravenous bolus, the rate of cardiovascular complications jumps to about 10 percent, and overdose errors become far more common. In one review, all recorded overdoses occurred with IV bolus administration, none with intramuscular injection.⁴

The reason is speed. An intramuscular injection releases adrenaline gradually as it diffuses out of muscle tissue. An IV bolus dumps the entire dose into the bloodstream in seconds, producing a peak concentration that the heart and blood vessels experience all at once. This is why emergency medicine guidelines generally reserve IV adrenaline for cardiac arrest, where the heart has already stopped and the risk calculus is entirely different. For anaphylaxis, intramuscular injection is the standard precisely because it provides a safety buffer against accidental overdose.

Even subcutaneous injection behaves differently from intramuscular. Adrenaline constricts blood vessels at the injection site, which paradoxically slows its own absorption. That self-limiting mechanism means subcutaneous doses tend to produce lower and later peak blood levels than intramuscular doses, though the clinical significance of this difference is mostly relevant at higher-than-intended doses.

How Adrenaline Damages the Heart

The heart is the organ most immediately threatened by an adrenaline overdose. Excess adrenaline overstimulates the receptors on heart muscle cells, forcing the heart to beat faster and harder than it can sustain. The downstream damage takes several forms.

The most dramatic is direct myocardial stunning, sometimes called Takotsubo syndrome or “broken heart syndrome.” In this condition, a surge of catecholamines causes the left ventricle to balloon outward and lose its ability to contract properly. Patients with Takotsubo show supraphysiological levels of circulating catecholamines, and the damage appears to stem from a combination of direct toxicity to heart muscle, spasm of coronary arteries, and sheer overwork.⁵ In clinical case reports, epinephrine given during treatment of allergic reactions has triggered Takotsubo, providing direct evidence that the drug itself can cause this form of heart failure.⁶

Dangerous heart rhythms are another route to death. Adrenaline increases the electrical excitability of the heart, making abnormal rhythms like ventricular tachycardia more likely. In a reported case of a prehospital epinephrine overdose in a five-year-old boy who received ten times the intended dose, the child developed ventricular dysrhythmias and signs of myocardial ischemia, meaning the heart muscle was being starved of oxygen even in a young, previously healthy patient.⁷ At high enough doses or in vulnerable individuals, these rhythms can deteriorate into ventricular fibrillation, which is lethal without immediate defibrillation.

The encouraging counterpoint is that much of this cardiac damage can be reversible. One early case report described severe ventricular dysfunction after an accidental adrenaline overdose followed by near-complete recovery of heart function.⁸ Another case of an IV epinephrine overdose in the prehospital setting resulted in tachycardia, severe headache, and biochemical markers of heart damage, but the patient recovered fully within 24 hours with no long-term damage visible on follow-up imaging.⁹ Survival depends heavily on whether the patient has access to intensive monitoring and rapid intervention during the acute crisis.

Damage Beyond the Heart

Adrenaline overdose does not only threaten the heart. The surge in blood pressure it produces can rupture blood vessels in the brain, causing intracerebral hemorrhage. This risk is particularly elevated in elderly patients, whose blood vessels may already be fragile. Case reports document intracranial bleeding after standard intramuscular adrenaline doses given for allergic reactions, leading researchers to recommend careful risk-benefit consideration before administering epinephrine to older patients when the severity of the reaction is unclear.¹⁰ Intracerebral hemorrhage has also been documented during anaphylactic shock treated with adrenaline, a scenario where it can be difficult to tell whether the bleeding was caused by the drug, the anaphylaxis itself, or both.¹¹

The lungs are vulnerable too. In animal experiments, high-dose adrenaline produced gross pulmonary edema, essentially flooding the lungs with fluid. The severity was dose-dependent, and the alpha-blocker phentolamine was protective at all but the highest doses tested.¹² In humans, pulmonary edema after adrenaline overdose is less well documented but physiologically expected at extreme doses.

Children Are Not Small Adults

Pediatric adrenaline overdoses deserve special attention because the margin between a therapeutic dose and a toxic one is much thinner in a small body. A three-year-old who accidentally received an IV adrenaline overdose developed a chaotic heart rhythm called multifocal atrial tachycardia, with abnormal electrical activity persisting on ECG monitoring for at least a year afterward.¹³ That case underscores how sensitive developing cardiac tissue is to sympathomimetic overstimulation.

Distinguishing adrenaline overdose from worsening anaphylaxis in a child is also harder than most clinicians realize. In one reported case involving a nine-year-old, the signs of adrenaline toxicity were clinically indistinguishable from progressive anaphylactic shock until a blood pressure reading was taken. The blood pressure was sky-high rather than dangerously low, pointing to overdose rather than under-treatment.¹⁴ The practical lesson is that blood pressure measurement should be routine in pediatric emergencies involving adrenaline, precisely because the two opposing problems look so similar from the outside.

How Dosing Errors Happen

If the lethal dose is so variable and the drug so dangerous intravenously, why do overdoses keep happening? Much of the answer lies in the confusing way adrenaline concentrations are labeled. Adrenaline comes in two common concentrations, traditionally expressed as ratios: 1:1,000 (1 mg per mL, intended for intramuscular use) and 1:10,000 (0.1 mg per mL, intended for IV use in cardiac arrest). If a clinician grabs the wrong vial or miscalculates the volume, the patient can receive ten times the intended dose.

In a controlled trial simulating emergency scenarios, healthcare providers using ratio-labeled ampules gave an average of 213 micrograms more adrenaline than intended and took longer to draw it up, compared with providers who had mass-concentration labels stating the actual milligrams per milliliter.¹⁵ This is a design problem, not a competence problem: the ratio system is inherently confusing even for experienced clinicians. In a separate simulation study, over half of participants committed some kind of error while administering epinephrine for a severe allergic reaction, with 8 percent delivering an outright overdose.¹⁶

Many countries have moved toward mass-concentration labeling to reduce these errors, but the transition is uneven, and older stock with ratio labels persists in many clinical settings.

Factors That Lower the Threshold

Several conditions make a person more vulnerable to adrenaline toxicity at doses that would be safe for someone else. Age is the most obvious: elderly patients are at higher risk for both cardiac arrhythmias and cerebrovascular complications. Pre-existing heart disease, particularly coronary artery disease, reduces the heart’s ability to tolerate the increased workload that adrenaline demands. Hyperthyroidism amplifies the cardiovascular effects of catecholamines, effectively lowering the danger threshold.

Drug interactions matter as well. Beta-blockers, paradoxically, can worsen the picture. While they block some of adrenaline’s cardiac effects, they leave the alpha-receptor-driven blood pressure spike unopposed, which can cause dangerous hypertension. In animal studies, long-term nitroglycerin treatment sensitized alpha-1 receptors and lowered adrenaline’s LD50 from about 11 mg/kg to 9 mg/kg, a meaningful reduction.³ Cocaine and certain antidepressants also potentiate adrenaline’s effects, as they block the reuptake mechanisms that normally clear catecholamines from the synaptic cleft.

Propranolol, a common non-selective beta-blocker, has been shown to reduce adrenaline clearance from the body by roughly 40 percent.² This means that for someone on propranolol, the same dose of adrenaline lingers in the bloodstream much longer, effectively increasing exposure even if the injected amount was appropriate.

When Your Own Body Produces a Lethal Dose

Exogenous injection is not the only way adrenaline levels can become toxic. Pheochromocytomas and paragangliomas are tumors of the adrenal glands or related nerve tissue that can secrete massive, uncontrolled bursts of catecholamines. During a crisis, these tumors flood the body with adrenaline and noradrenaline at levels far beyond what any physician would deliberately administer. In a case series from a tertiary referral center, one out of six patients experiencing a pheochromocytoma crisis died, and three of the four survivors developed Takotsubo-pattern cardiac injury requiring intensive care.¹⁷

These cases demonstrate that endogenous adrenaline can be just as lethal as an injected overdose. The clinical picture mirrors iatrogenic overdose almost exactly: hypertensive crisis, cardiac arrhythmias, heart failure, and pulmonary edema. The difference is that the source keeps pumping out catecholamines until the tumor is removed or the crisis is pharmacologically controlled, making sustained high levels more likely than with a single injection.

Reversing the Effects

When adrenaline overdose is caught quickly, the drug phentolamine serves as an antidote for one of the most common complications: dangerous vasoconstriction. Phentolamine blocks alpha-adrenergic receptors, counteracting the intense blood vessel narrowing that adrenaline causes. In accidental digital injections, where a person jabs themselves in the finger with an EpiPen, phentolamine reliably reversed the resulting ischemia within about 85 minutes, compared with roughly 320 minutes for the vasoconstriction to resolve on its own without treatment.¹⁸ In one case, injecting half a milligram of phentolamine into a darkened, ischemic finger produced visible pinkening almost immediately, with near-normal skin color returning within 25 minutes.¹⁹

For systemic overdose affecting the heart, the picture is more complex. There is no single “adrenaline antidote” the way naloxone reverses opioids. Management is supportive: controlling blood pressure with short-acting vasodilators, treating arrhythmias as they arise, and providing mechanical ventilation if pulmonary edema develops. The rapid clearance rate of adrenaline works in the patient’s favor here. Because the body metabolizes it within minutes, the acute crisis is usually short-lived if the patient can be stabilized through it. The challenge is surviving those minutes.

Detecting Adrenaline Poisoning After Death

Adrenaline presents a unique forensic problem. Because the body produces it naturally, and because stress, pain, and the dying process itself all cause massive catecholamine release, finding elevated adrenaline in postmortem blood does not prove someone was given an overdose. Decomposition further complicates things, as catecholamine levels change after death.

Forensic toxicologists have worked around this by measuring not adrenaline itself but its metabolic byproducts. The ratio of metanephrine to normetanephrine in plasma has been identified as the most reliable marker for distinguishing exogenous adrenaline administration from the body’s own production.²⁰ When someone receives a large dose of exogenous adrenaline, the ratio is skewed heavily toward metanephrine in a pattern that normal stress responses do not produce. This has become an important tool in suspected poisoning cases, though it still requires that blood samples be collected and preserved properly.

Catecholamine Toxicity in Other Species

Humans are not the only animals vulnerable to lethal catecholamine surges. Capture myopathy is a well-documented condition in wildlife, where the extreme stress of being chased, trapped, or restrained triggers a catecholamine flood that damages the heart and skeletal muscles, sometimes fatally. The pathophysiology closely parallels what happens in human adrenaline overdose and Takotsubo syndrome.²¹ Zebras, deer, and flamingos are among the species most susceptible. The condition is a significant concern for wildlife conservationists who need to tranquilize and relocate animals, because the stress of the capture itself can trigger the same catecholamine-driven cardiac failure that an adrenaline injection can cause in humans. It serves as a reminder that the lethal potential of adrenaline is not a pharmacological quirk but a fundamental vulnerability shared across mammals.